Skip to main content

and
  1. No Access

    Article

    A role of NR4A2 in Graves’ disease: regulation of Th17/Treg

    This study aimed to explore the molecular pathogenesis of Graves’ disease (GD).

    Shuiying Zhao, **nyu Wang, Fengjiao Huang, Yingying Zhou, Dongdong Meng in Endocrine (2024)

  2. No Access

    Article

    Increased chemokine (C–C motif) ligand 21 expression and its correlation with osteopontin in Graves’ disease

    Graves’ disease (GD) is a chronic autoimmune process characterized by the production of auto-antibodies that presumably consequent to the lymphocytic infiltrates in the thyroid. Chemokine (C–C motif) ligand 21...

    Yicheng Qi, **aoli Li, Qianwei Zhang, Fengjiao Huang, Dong** Lin, Yulin Zhou in Endocrine (2015)

  3. No Access

    Article

    Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy

    Glucocorticoid (GC) insensitivity occurs commonly in Graves’ ophthalmopathy (GO), and GC therapy is associated with major adverse effects. A reliable and easily accessible biomarker is required to predict the ...

    Liyun Shen, Fengjiao Huang, Lei Ye, Wei Zhu, **aofang Zhang, Shu Wang in Endocrine (2015)